EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders

Shahid Mohammad, Li Wang, Masaaki Torii, Kazue Hashimoto-Torii iD

International Journal of Neuropsychopharmacology · 2025

DOI: 10.1093/ijnp/pyaf055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Shahid Mohammad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroscience Research, Children's Research Institute, Children's National Hospital, Washington, DC, United States. Hauptthemen laut MEDLINE: Fetal Alcohol Spectrum Disorders, Scorpion Venoms, Reversal Learning, Cognitive Dysfunction. Die Arbeit nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIH HHS, Scott-Gentle Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fetal alcohol spectrum disorders (FASD) show a myriad of cognitive and neurological deficits, with the prevalence estimated to be 1% to 5 % in children. To date, there are no effective treatments for these deficits in FASD. In a mouse model of FASD, daily intraperitoneal administration of a potassium calcium-activated channel subfamily N member 2 (KCNN2) blocking peptide has been shown to improve motor learning deficits due to upregulation of KCNN2 channels. This study investigates whether intranasal administration of a KCNN2 blocking peptide, Leiurotoxin-1 Dab7 (Lei-Dab7), can improve cognitive flexibility, specifically reversal learning deficits, in these mice.

Methods

We utilized a mouse model of prenatal alcohol exposure. Cognitive flexibility was assessed using the water T-maze test at postnatal day 40. Lei-Dab7’s specificity and cytotoxicity were evaluated in vitro, and intranasal delivery efficiency was confirmed through immunohistochemistry, quantifying its distribution and binding to neurons with elevated KCNN2 expression in the prefrontal cortex.

Results

Lei-Dab7 showed high specificity and negligible cytotoxicity in vitro. Intranasal administration efficiently delivered Lei-Dab7 to the prefrontal cortex, where it specifically bound to neurons expressing increased KCNN2 channels. Behavioral tests demonstrated that Lei-Dab7 significantly improved cognitive flexibility, reversing the deficits in the water T-maze test seen in ethanol-exposed mice, without apparent acute physiological adverse effects.

Conclusions

Intranasal administration of KCNN2 blockers, such as Lei-Dab7, represents a promising, non-invasive therapeutic approach for treating cognitive inflexibility and possibly other cognitive dysfunctions associated with FASD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fetal Alcohol Spectrum DisordersScorpion VenomsReversal LearningCognitive DysfunctionAnimalsAdministration, IntranasalDisease Models, AnimalMiceFemalePregnancyMaleMaze LearningMice, Inbred C57BLPrefrontal CortexBehavior, AnimalCognitive Flexibility

Stichwörter der Autor:innen

KCNN2cognitive flexibilityfetal alcohol spectrum disordersintranasal administrationprefrontal cortex

Substanzen

Scorpion Venoms

Autor:innen und Institutionen

  • Center for Neuroscience Research, Children's Research Institute, Children's National Hospital, Washington, DC, United States.
  • Department of Pediatrics, Pharmacology and Physiology, School of Medicine and Health Sciences, George Washington University, Washington, DC, United States.

ORCID-Profile: Kazue Hashimoto-Torii

Förderung

  • NIAAA NIH HHS
  • NIH HHS
  • Scott-Gentle Foundation
  • National Institutes of Health, District of Columbia Intellectual and Developmental Disabilities Research Center award program
  • NICHD NIH HHS
  • National Institutes of Health

Zitieren

APA

Mohammad, S., Wang, L., Torii, M., & Hashimoto-Torii, K. (2025). Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf055

Vancouver

Mohammad S, Wang L, Torii M, Hashimoto-Torii K. Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf055

BibTeX
@article{Mohammad2025,
  author = {Mohammad, Shahid and Wang, Li and Torii, Masaaki and Hashimoto-Torii, Kazue},
  title = {Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2025},
  doi = {10.1093/ijnp/pyaf055}
}
Kostenlos starten →